Financials
- Market Capitalization 25.95 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
14.44
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 469 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 63.88 USD | +1.22% | +3.17% | +7.31% | +71.44% | 28.53 B USD | ||
| 483 | INSM Insmed Incorporated - Common Stock | 126.68 USD | +0.04% | +5.24% | +27.75% | -21.83% | 27.66 B USD | ||
| 514 | ROIV Roivant Sciences Ltd. - Common Shares | 34.41 USD | +0.67% | -7.03% | -1.38% | +87.93% | 24.86 B USD | ||
| 518 | BNTX BioNTech SE - American Depositary Shares | 102.88 USD | -0.90% | +0.61% | +12.54% | -9.13% | 24.69 B USD |